The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The ACR Is Exploring a Rheumatology-Specific APM

The ACR Is Exploring a Rheumatology-Specific APM

June 15, 2017 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In response to the required changes in reimbursement from fee for service to value-based payment under the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, the ACR is exploring development of a rheumatology-specific alternative payment model (APM) for rheumatologists and practices, which would provide an additional option for payment other than the Merit-Based Incentive Payment System (MIPS).

You Might Also Like
  • Update on ACR’s Rheumatology-Specific APM
  • Prepare Now—Not Later—to Meet New Medicare Reimbursement Requirements
  • MACRA Has Arrived—& What You Do Now Counts
Also By This Author
  • Evolutionary Medicine Provides Insight into the Chronic Inflammatory State Note Rheumatologists at the 2013 ACR/ARHP Annual Meeting

APMs to Outlast MIPS
Under MACRA, physicians and practices who take Medicare patients can opt to participate in one of two different systems of value-based reimbursement: the Merit-Based Incentive Payment System (MIPS) or an Alternative Payment Model (APM). Although all physicians who accept Medicare will automatically be enrolled in MIPS unless they meet exemption requirements, it is anticipated that APMs will be increasingly adopted.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“The MIPS program was not designed to be sustainable for practices in the long run,” says Kwas Huston, MD, the Center for Rheumatic Disease, Kansas City, Mo., saying that inherent pressures within MIPs are pushing physicians toward APMs.

Creating an RA-Specific APM
Dr. Huston, along with Edward Herzig, MD, is co-chair of an ACR working group that is working toward a potential APM that would focus on rheumatoid arthritis (RA). The working group consists of ACR members in a variety of practice settings and geographic areas. Dr. Huston emphasizes that the ACR believes rheumatologists will be better served if a rheumatology-specific APM is developed by the ACR rather than an outside group, such as the Centers for Medicare & Medicaid Services (CMS).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

However, he underscores that the goal of the APM is to help rheumatology practices thrive and improve their financial performance. “We hope an APM will work better for patients and physicians by eliminating some of the impediments to care, such as prior authorization; paying for non-face-to-face interactions with patients; and providing steady and predictable revenue for patient care,” he says.

Current APM Status
The ACR is working with an expert consultant on this project and has sought input from a wide variety of stakeholder groups to make sure that a potential payment model is feasible and can be incorporated into practice.

To date, the working group has developed a working draft proposal and is in the midst of refining various elements.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

According to Drs. Herzig and Huston, once the draft proposal is refined, it will be presented to the ACR Committee on Rheumatologic Care (CORC) and the ACR Board of Directors. The end goal will be to present a model to the U.S. Government Accountability Office’s Payment Model Technical Advisory Committee (PTAC) so that it could be recommended to and approved by the CMS as an APM that can be used by rheumatologists, if desired.

“Eventually, we would hope to expand the RA model to other rheumatic diseases,” says Dr. Huston. “The APM model will be flexible enough that it could be applied to any rheumatology practice, whether independent, employed, single- or multi-specialty, or academic,” he says.


Mary Beth Nierengarten is a freelance medical journalist based in Minneapolis.

 

Pages: 1 2 | Multi-Page

Filed Under: Practice Management, Professional Topics Tagged With: Alternative Payment Model (APM), Merit-based incentive payment system, RA-Specific APM, Rheumatoid Arthritis (RA)

You Might Also Like:
  • Update on ACR’s Rheumatology-Specific APM
  • Prepare Now—Not Later—to Meet New Medicare Reimbursement Requirements
  • MACRA Has Arrived—& What You Do Now Counts
  • Quality Update Reporting Changes under MACRA

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)